Home/ Supplements/ Ephedra/ Yellow Scorpion W/ 25 mg Ephedra Extract

Yellow Scorpion W/ 25 mg Ephedra Extract

product on market Capsule Hi-Tech Pharmaceuticals Safety: 90/100
90/100

This product looks safe

  • Contains proprietary blend — exact ingredient amounts not disclosed
  • Limited research evidence available for ingredients
B Label Compliance Grade
Alerts

Safety Alerts

Contains proprietary blend — exact ingredient amounts not disclosed

Label

Product Label

Label for Yellow Scorpion W/ 25 mg Ephedra Extract
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
90
Servings
Other Combinations
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Proprietary Blend
575 mg

Other Ingredients

Dicalcium Phosphate Sodium Starch Glycolate Magnesium Stearate Silica FD&C Blue # 1 FD&C Red #40 FD&C Yellow #6
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Dosage: Take 1 capsule three times daily.

Warnings & Precautions

Do not exceed 4 capsules in any 24 hour period.

Warning: Not for use by individuals under the age of 18 years.

Do not use if you are pregnant or nursing. This product can raise blood pressure and interfere with other drugs you may be taking.

Talk to your doctor about this product.

(Warnings/information continued on back of label)

Sale to persons 17 years of age or younger is prohibited.

Tamper Evident Do not use if printed seal is cut, torn or missing

Individuals who consume caffeine with this product may experience serious adverse health effects. Individuals who are sensitive to the effects of caffeine should consult a licensed health care professional before consuming this product. Individuals who are sensitive to the effects of caffeine should consult a doctor before consuming this product.

Do not consume synephrine or caffeine from other sources, including but not limited to, coffee, tea, soda or other dietary products or medications containing caffeine or phenylephrine.

Do not use for more than 8 weeks.

Consult with your physician prior to use if you are taking medication, including but not limited to MAOI inhibitors, aspirin, antidepressants, nonsteroidal anti-inflammatory drugs or products containing phenylephrine ephedrine, pseudoephedrine, or other stimulants.

Consult your physician prior to use if you have a medical condition, including but not limited to, heart, liver, kidney, or thyroid disease, psychiatric or epileptic disorders, difficulty urinating, diabetes, high blood pressure, cardiac arrhythmia, recurrent headaches, enlarged prostate or glaucoma. Discontinue 2 weeks prior to surgery or if you experience rapid heart beat, dizziness, severe headache or shortness of breath. In case of accidental overdose, seek professional assistance or contact a poison control center immediately. Avoid alcohol while taking this product. Exceeding recommended serving may cause serious adverse health effects, including heart attack and stroke. Improper use of this product may be hazardous to a persons health.

Additional Information

HTP HI-TECH PHARMACEUTICALS

Ultimate energizer Feel the sting!

90 ct

Peel Here

To report adverse effects call FDA's MedWatch at 1-800-332-1088

Metadata

Product Details

UPC / SKU8 57084 00093 4
DSLD Entry Date2015-08-25
Product TypeOther Combinations
FormCapsule
DSLD ID48169
Data Updated2026-04-11
Research

Research Evidence

11
Research Sources
44
Avg Quality
7
Rct
3
Meta Analysis
B Scopolamine (hyoscine) for preventing and treating motion sickness
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
C Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis
Meta Analysis JAMA 2003 PubMed
C Methanolic extract of Ephedra ciliata promotes wound healing and arrests inflammatory cascade in vivo through downregulation of TNF-α
Meta Analysis Inflammopharmacology 2020 PubMed DOI
C Acute effect of ephedrine on 24-h energy balance
Rct Clinical science (London, England : 1979) 1999 PubMed
C Effects of chronic administration of ephedrine during very-low-calorie diets on energy expenditure, protein metabolism and hormone levels in obese subjects
Rct Clinical science (London, England : 1979) 1992 PubMed
C Hemodynamic effects of ephedra-free weight-loss supplements in humans
Rct The American journal of medicine 2005 PubMed
D Caffeine-herbal ephedra combination increases resting energy expenditure, heart rate and blood pressure
Rct Clinical and experimental pharmacology & physiology 2005 PubMed
D Electrocardiographic effects of an Ephedra-Free, multicomponent weight-loss supplement in healthy volunteers
Rct Pharmacotherapy 2005 PubMed
D Does ephedrine promote weight loss in low-energy-adapted obese women?
Rct International journal of obesity 1987 PubMed
D The effect of ephedrine plus caffeine on smoking cessation and postcessation weight gain
Rct Clinical pharmacology and therapeutics 1996 PubMed
View all evidence for Ephedra →
Compare

Similar Products

View all Ephedra products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.